144 related articles for article (PubMed ID: 23387388)
41. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
43. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
Nishimura M; Ikeda T; Ushiyama M; Nanbu A; Kinoshita S; Yoshimura M
J Clin Endocrinol Metab; 1999 Feb; 84(2):659-62. PubMed ID: 10022434
[TBL] [Abstract][Full Text] [Related]
44. Intraocular expression of thymosin β4 in proliferative diabetic retinopathy.
Wang JY; Lu Q; Tao Y; Jiang YR; Jonas JB
Acta Ophthalmol; 2011 Aug; 89(5):e396-403. PubMed ID: 21332672
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
[TBL] [Abstract][Full Text] [Related]
46. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.
El-Asrar AM; Missotten L; Geboes K
Mol Vis; 2011 Feb; 17():508-18. PubMed ID: 21365018
[TBL] [Abstract][Full Text] [Related]
47. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
48. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
[TBL] [Abstract][Full Text] [Related]
49. Thrombospondin: a new attachment protein in preretinal traction membranes.
Weller M; Esser P; Bresgen M; Heimann K; Wiedemann P
Eur J Ophthalmol; 1992; 2(1):10-4. PubMed ID: 1353387
[TBL] [Abstract][Full Text] [Related]
50. Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes.
Abu El-Asrar AM; Missotten L; Geboes K
Clin Exp Ophthalmol; 2010 Jan; 38(1):57-64; quiz 87. PubMed ID: 20447102
[TBL] [Abstract][Full Text] [Related]
51. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
[TBL] [Abstract][Full Text] [Related]
52. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.
Hinton DR; Spee C; He S; Weitz S; Usinger W; LaBree L; Oliver N; Lim JI
Diabetes Care; 2004 Mar; 27(3):758-64. PubMed ID: 14988298
[TBL] [Abstract][Full Text] [Related]
53. Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes.
El-Asrar AM; Missotten L; Geboes K
Br J Ophthalmol; 2008 Nov; 92(11):1534-9. PubMed ID: 18952655
[TBL] [Abstract][Full Text] [Related]
54. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107
[TBL] [Abstract][Full Text] [Related]
55. Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.
Abu El-Asrar AM; Struyf S; Opdenakker G; Van Damme J; Geboes K
Mol Vis; 2010 Jun; 16():1098-107. PubMed ID: 20596251
[TBL] [Abstract][Full Text] [Related]
56. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
Simó R; Higuera M; García-Ramírez M; Canals F; García-Arumí J; Hernández C
Arch Ophthalmol; 2008 Aug; 126(8):1076-81. PubMed ID: 18695102
[TBL] [Abstract][Full Text] [Related]
57. Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mousa A; De Hertogh G; Opdenakker G
PLoS One; 2013; 8(12):e85857. PubMed ID: 24392031
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
[TBL] [Abstract][Full Text] [Related]
59. The significance of vitronectin in proliferative diabetic retinopathy.
Esser P; Bresgen M; Weller M; Heimann K; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):477-81. PubMed ID: 7523258
[TBL] [Abstract][Full Text] [Related]
60. Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy.
Tan K; Lessieur E; Cutler A; Nerone P; Vasanji A; Asosingh K; Erzurum S; Anand-Apte B
Exp Eye Res; 2010 Aug; 91(2):229-37. PubMed ID: 20493838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
